Avience Biomedicals SME IPO Details, Financials, Valuation & Peers

Avience Biomedicals Limited, incorporated in June 2024, is an ISO certified company specializing in the manufacturing, supply, and export of molecular diagnostic solutions. The company's core business revolves around biotechnology, genomics, and the In Vitro Diagnostics (IVD) industry.

Avience Biomedicals offers a comprehensive range of products and services, including IVD rapid test kits, serology products, biochemistry analyzers and reagents, molecular diagnostics (such as COVID-19 detection kits), hematology analyzers, and medical devices including oxygen concentrators and viral transport solutions. In addition to manufacturing, the company also acts as a distributor and trader of medical equipment.

Key highlights of Avience Biomedicals include:

• Diverse Product Portfolio: Offers a wide array of diagnostic solutions, from rapid test kits to advanced analyzers and molecular diagnostics.
• B2B and B2G Focus: Exclusively caters to the Business-to-Business (B2B) and Business-to-Government (B2G) markets.
• Broad Customer Base: Products serve Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide and overseas.
• Quality Assurance: Complies with ISO standards and regulatory approvals, with stringent quality control processes.
• Growing Reach: Possesses a strong distribution network across India and is expanding its international footprint.